| Dr Richard P Smith, MD | |
|
1600 Nashville Hwy, Columbia, TN 38401-1004 | |
| (931) 388-8965 | |
| (931) 840-8520 |
| Full Name | Dr Richard P Smith |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1600 Nashville Hwy, Columbia, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053521401 | NPI | - | NPPES |
| 5441790 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 42601 (Tennessee) | Secondary |
| 208000000X | Pediatrics | MD42601 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard P Smith, MD 1600 Nashville Hwy, Columbia, TN 38401-1004 Ph: (931) 388-8965 | Dr Richard P Smith, MD 1600 Nashville Hwy, Columbia, TN 38401-1004 Ph: (931) 388-8965 |
News Archive
The Southern Atlantic Healthcare Alliance (SAHA) has selected TeleTracking's RadarFind as the exclusive real-time locating provider for member hospitals. SAHA, which is comprised of 16 hospitals in North Carolina, chose RadarFind's real-time location system (RTLS) to enable their members to track medical equipment, patients and staff.
Emotional and behavioral problems show up even with low exposure to lead, and as blood lead levels increase in children, so do the problems, according to research funded by the National Institute of Environmental Health Sciences, part of the National Institutes of Health. The results were published online June 30 in the journal JAMA Pediatrics.
A study from Thomson Reuters released today shows that the US is no longer the "colossus of science" that it was and has not kept pace with the increased output from European and Asia-Pacific nations.
Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that it has advanced into drug development a discovery research candidate directed against PCSK9 (proprotein convertase subtilisin/kexin type 9), an important new target for the treatment of high cholesterol. Using its proprietary Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine, Santaris Pharma A/S identified and advanced the new drug, SPC5001, in just 18 months.
› Verified 8 days ago
Dr. Andrew Karl Nielsen, M.D. Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 854 W James M Campbell Blvd Ste 403, Columbia, TN 38401 Phone: 931-380-0075 Fax: 931-388-7502 | |
Dr. Mary Overton, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 Nashville Hwy, Columbia, TN 38401 Phone: 931-388-8965 Fax: 931-840-8520 | |
Kelley Vincent Jefferson, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1224 Trotwood Ave, Columbia, TN 38401 Phone: 931-359-4506 Fax: 931-490-7043 | |
Dr. Claudia Sainz Andrews, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1222 Trotwood Ave, Suite 101, Columbia, TN 38401 Phone: 931-388-8965 Fax: 931-840-8520 | |
Dr. Thomas Wade Denney, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 Nashville Hwy, Columbia, TN 38401 Phone: 931-388-8965 Fax: 931-840-8520 | |
Laurie Tucker, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 Nashville Hwy, Columbia, TN 38401 Phone: 931-388-8965 |